Buscar
Mostrando ítems 1-10 de 163
COVID-19 pneumonia and tocilizumab useNeumonía por COVID-19 y uso de tocilizumab
(Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana, 2020)
First Report of Tocilizumab Use in a Cohort of Latin American Patients Hospitalized for Severe COVID-19 Pneumonia
(2020)
Introduction/objectives: An interleukin-6 inhibition strategy could be effective in
selected COVID-19 patients. The objective is to present our experience of tocilizumab
use in patients with severe COVID-19.
Methods: ...
Judicialização de medicamentos off label e pandemia: tocilizumabe nas demandas judiciais do estado do Rio Grande do Norte
(Universidade Federal do Rio Grande do NorteBrasilUFRNDireitoDepartamento de Direito, 2022-07-26)
The judicialization of the SUS is a phenomenon in which lawsuits are tools for accessing health products and services, realizing the constitutionally guaranteed right. Among the demands, the supply of medicines is the one ...
First Report of Tocilizumab Use in a Cohort of Latin American Patients Hospitalized for Severe COVID-19 Pneumonia
(2020)
Introduction/objectives: An interleukin-6 inhibition strategy could be effective in selected COVID-19 patients. The objective is to present our experience of tocilizumab use in patients with severe COVID-19. Methods: ...
Uso del tocilizumab para el tratamiento de pacientes con Covid-19
(Seguro Social de Salud (EsSalud)PE, 2020-08-17)
La evidencia disponible a la fecha (14 de agosto de 2020) corresponde al reporte preliminar de dos ensayos clínicos de fase III, que no han encontrado beneficio atribuible a tocilizumab con respecto a desenlaces clínicamente ...